insights_auto
Why is GH up 2,50%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
US$166,66
arrow_upward
+2,50%(+4,07) 1D
US$166,66
0,00% (0,00)
bedtimeAfter hours
Closed: 21 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
US$162,29
High
US$171,22
Low
US$162,00
Mkt. cap
22,37 ຕື້
Avg. vol.
1,78 ລ້ານ
Volume
193,00
52-wk high
US$191,01
52-wk low
US$66,59
EPS
US$-3,50
Beta
1,58
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
Open
US$162,29
High
US$171,22
Low
US$162,00
Mkt. cap
22,37 ຕື້
Avg. vol.
1,78 ລ້ານ
Volume
193,00
52-wk high
US$191,01
52-wk low
US$66,59
EPS
US$-3,50
Beta
1,58
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
News Corp
·
15 ຊົ່ວໂມງກ່ອນ
7 healthcare stocks that stand out as investors pay up for the sector
Zacks
·
21 ຊົ່ວໂມງກ່ອນ
Natera Partners With TransCode to Advance Colorectal Cancer Trial
Stocks Down Under
·
2 ມື້ກ່ອນ
Guardant Health (NDQ:GH): The Company Betting Its Cancer Screening Method Will Be Revolutionary!
Seeking Alpha
·
2 ມື້ກ່ອນ
Guardant Health: Growth Remains Too Expensive, Reiterate Hold (NASDAQ:GH)
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 ພັນ
Founded2012
HeadquartersPalo Alto, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth care provider
Websiteguardanthealth.com